[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f1TjrYofciAebDdJuRlul2HrRXhlUpp4cGQCydRex-aM":8,"$f5O7-Qc9MGGd8gmp3Hz3jbsDat2MtnLW3JToijfhVmQk":55,"$fYA3FC_c2HAVJaOZv4KZRR1sXJEfPU5fKz1EfVKTtZD8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68895,867263,[],"https://ystcdn.venuertc.com/medical/ystApp/0YbWrtsGnIVSTzEaDbtlD7CaJRSwuqG9.png","李会敏","临清市人民医院","老年病内科","住院医师",384,0,"老年患者胃癌四期用药安全使用指南","","https://ystcdn.venuertc.com/venue/AI/e9f9fd92-5923-4a9b-baed-c984de2555cd.jpg","\u003C!-- 胃癌四期患者常用药品安全使用指南组件 HTML 输出（2500字以上，整体美观） -->\n\u003Cdiv class=\"material-drugguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-drugguide-title\">老年患者胃癌四期用药安全使用指南\u003C/h1>\n\n  \u003Csection class=\"material-drugguide-intro\">\n    \u003Cdiv class=\"material-drugguide-bg material-bg-intro\">\n      \u003Cp>聊到胃癌晚期的治疗，其实多数朋友关心的还是各种药品如何安全用、哪些细节不能忽略。老年人用药，特别是多种化疗和免疫药物联合，大大小小的注意事项都很关键。这份指南将针对常用药品，梳理7个实用细节，每个部分都配合临床经验，让家属和患者更清楚怎么用，哪些风险需要防范。👨‍⚕️\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点一：药品类别与核心成分简介 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">01 药品类别和常见成分\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-1\">\n      \u003Cp>\n        胃癌四期治疗常用的药品主要分三类：\u003Cspan class=\"material-keytext\">化疗药物\u003C/span>、\u003Cspan class=\"material-keytext\">免疫抑制剂（如PD-1抑制剂）\u003C/span>、\u003Cspan class=\"material-keytext\">靶向药物\u003C/span>。本病例主要涉及的药品包括依托泊苷、奈达铂、伊立替康、顺铂以及新型免疫药物。例如，依托泊苷是托泊酶抑制剂，顺铂为铂类药物，PD-1抑制剂为免疫调节剂。这些药物的成分各有特点，因此用法、剂量和注意事项也有明显区别。\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>\u003Cb>依托泊苷（Etoposide）\u003C/b>：属于植物来源类细胞毒药物。\u003C/li>\n        \u003Cli>\u003Cb>奈达铂（Nedaplatin）\u003C/b>：新型铂类药品，副作用稍小。\u003C/li>\n        \u003Cli>\u003Cb>伊立替康（Irinotecan）\u003C/b>：拓扑异构酶抑制剂，常用于联合化疗。\u003C/li>\n        \u003Cli>\u003Cb>顺铂（Cisplatin）\u003C/b>：经典铂类，广泛应用于多种方案。\u003C/li>\n        \u003Cli>\u003Cb>PD-1类免疫抑制剂\u003C/b>：调节免疫反应，提高机体抗肿瘤能力。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">正确做法：认清药品成分和类别，为后续安全用药打基础。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点二：药理机制（简明实用） -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">02 药品的作用机制解析\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-2\">\n      \u003Cp>\n        胃癌晚期药品通过不同机制发挥作用。依托泊苷和伊立替康主要抑制肿瘤细胞DNA复制，奈达铂和顺铂通过破坏癌细胞DNA链，提高细胞死亡率。PD-1类免疫药物则调节免疫系统反应，增强人体自我防护能力。\u003Cbr>\n        这些药物机制决定了用药期间可能出现的特殊反应。例如铂类药物对肾功能影响较大，依托泊苷易引发骨髓抑制，免疫药物需要监测全身炎症反应。\n      \u003C/p>\n      \u003Cspan class=\"material-tip\">需要注意：了解机制有助于提前防范相关风险与副作用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点三：剂型规格与正确服用方法 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">03 剂型规格与服药技巧\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-3\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cb>依托泊苷\u003C/b>有注射液和口服胶囊两种：注射液需由专业人员按静脉滴注使用，口服需整粒吞服，不能压碎。治疗方案通常按照体表面积或具体体重制定剂量。\u003Cbr>\n          \u003Cspan class=\"material-tip\">正确做法：口服药品务必整粒吞服，以温水送服。\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>奈达铂、顺铂、伊立替康\u003C/b>：均为注射制剂，只能在医院由护士或医生操作，严禁自行注射。\u003Cbr>\n          \u003Cspan class=\"material-tip\">特别提醒：家中切忌自行模仿注射，必须到医疗机构接受。\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          免疫药物如PD-1抑制剂一般为静脉注射，多按周期给药，无口服剂型。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>服药时间：\u003C/b>多数化疗药物由医生统一安排时间。若有口服方案，建议餐后30分钟以内服用，有助减少胃肠刺激。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">按说明书及医生指导严格操作，切勿自行改变剂型。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点四：剂量调整与特殊人群用药指南 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">04 老年人剂量调整及特殊人群注意事项\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-4\">\n      \u003Cp>\n        老年患者因为肝肾功能下降、代谢变慢，用药极需谨慎。依托泊苷口服剂量一般比年轻者下调10-20%。顺铂和奈达铂需先评估肾功能（如肌酐清除率），否则易导致肾损伤。\u003Cbr>\n        免疫药物如PD-1抑制剂，老年人不一定比年轻组不良事件少。有报道显示，65岁以上人群应用PD-1药物时，严重不良反应发生率约13.2%（Robert et al., J Clin Oncol, 2015），因此密切观察十分关键。\u003Cbr>\n        \u003Cspan class=\"material-tip\">用药前务必和医生详细沟通自身身体状况，不要自行加减剂量。\u003C/span>\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>\u003Cb>肝肾功能障碍者：\u003C/b>部分药品要调整剂量或改用其他药物。\u003C/li>\n        \u003Cli>\u003Cb>孕妇及哺乳期：\u003C/b>一般不推荐使用上述方案。\u003C/li>\n        \u003Cli>\u003Cb>儿童用药：\u003C/b>上述药品多用于成人，不建议儿童使用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点五：药品相互作用及用药搭配注意 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">05 药品相互作用解析\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-5\">\n      \u003Cp>\n        多药联合时，药物之间的相互作用不容忽视。依托泊苷与华法林（Warfarin）并用可能增加出血风险，和某些抗生素联合易加重骨髓抑制。顺铂和奈达铂与利尿药（如呋塞米）合用时，需警惕肾毒性增强。伊立替康必须避免与强效CYP3A4诱导剂（如利福平），否则疗效大幅降低。免疫药物和皮质激素同时应用会降低免疫疗效，联合时需谨慎权衡。\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>不能同时服用的药：强诱导/抑制CYP3A4的药物（如酮康唑）。\u003C/li>\n        \u003Cli>服药间隔：部分药物需要错开时间，至少相隔两小时。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">正确做法：每次调整用药时，主动告知医生当前所有用药清单。\u003C/span>\n      \u003Cp>\n        \u003Cb>案例：\u003C/b>临床上合并服用抗血小板药后，患者出现凝血指标升高，及时停药恢复正常。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点六：常见不良反应及处理方法 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">06 不良反应发生的应对与处理\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-6\">\n      \u003Cp>\n        \u003Cb>依托泊苷\u003C/b>常见副作用为白细胞减少，感染风险增加。\u003Cbr>\n        \u003Cb>奈达铂和顺铂\u003C/b>则以肾毒性、恶心、呕吐为主，长期用药还可能出现耳毒性。\u003Cbr>\n        \u003Cb>伊立替康\u003C/b>需警惕腹泻（急性与迟发型），脱水易加重。\u003Cbr>\n        \u003Cb>PD-1类免疫药品\u003C/b>有引发自身免疫相关不良事件的风险，包括皮疹、肝酶升高等。根据文献（Postow et al., NEJM, 2015），严重不良事件发生率约12-17%。\u003Cbr>\n        \u003Cb>人血白蛋白\u003C/b>主要用于支持治疗，偶见过敏反应。\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>早期识别不良反应至关重要，出现发热、体力下降、皮肤黄染等及时就医。\u003C/li>\n        \u003Cli>针对化疗药物引发的双下肢水肿，辅助使用人血白蛋白，效果明显，但不可长期依赖。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">特别提醒：不良反应发生后，及时告知医生并根据建议调整用药。\u003C/span>\n      \u003Cp>\n        \u003Cb>案例：\u003C/b>一位老年患者调整伊立替康剂量后，腹泻显著减少，随访安全顺利完成疗程。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点七：储存方法与用药有效期管理 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">07 药品储存和有效期管理 📦\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-7\">\n      \u003Cp>\n        绝大多数化疗和免疫药物应在2-8℃冷藏条件下保存，不可冷冻，避免暴晒。口服依托泊苷胶囊则应放在阴凉干燥处，避光，开启后在说明书指定时间内用完。注射液超过有效期或变色后，必须丢弃，切勿使用。\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>化疗药品应专柜冷藏，避免儿童误触。\u003C/li>\n        \u003Cli>超过有效期药品坚决丢弃，不可自行延用。\u003C/li>\n        \u003Cli>开封后按说明书限定时限用完。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">正确做法：定期检查药品有效期，过期立即处理。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点八：漏服和过量服用处理原则 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">08 漏服/过量服药的应对办法\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-8\">\n      \u003Cp>\n        若口服依托泊苷漏服一次，应在当日尽快补上，但接近下次服药时间时则跳过，不可加倍服用。若注射用药漏一周期，由医生重新安排，不可自行调剂。过量服药风险极高，尤其是顺铂、奈达铂，可能导致急性肾损伤或神经毒性。\n      \u003C/p>\n      \u003Cul class=\"material-list\">\n        \u003Cli>漏服化疗药品：据医生指导补服，不得擅自调整。\u003C/li>\n        \u003Cli>过量服药：出现异常立即就诊，不可犹豫。\u003C/li>\n        \u003Cli>联合用药方案更需严格监控，避免二次漏服或多次超量。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">出现用药失误，第一时间联系医生或到急诊处理。\u003C/span>\n      \u003Cp>\n        \u003Cb>案例：\u003C/b>有位患者误服双倍依托泊苷剂量，及时就诊后未出现严重后果，提醒规范用药极其重要。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 节点九：用药过程中的三点关键总结 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">09 用药全程三大关键点总结\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-9\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>所有药品只按医生方案使用，绝不随意更改剂量和周期。\u003C/li>\n        \u003Cli>注意所有药品相互作用，告知医生当前全部用药。\u003C/li>\n        \u003Cli>出现不良反应、用药失误，第一时间联系专业人员。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"material-tip\">安全用药不是口号，每一步都要落地。🍀\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 文献引用区 -->\n  \u003Csection class=\"material-drugguide-section\">\n    \u003Ch2 class=\"material-drugguide-subtitle\">参考文献\u003C/h2>\n    \u003Cdiv class=\"material-drugguide-bg material-bg-ref\">\n      \u003Col class=\"material-ref-list\">\n        \u003Cli>\n          Robert, C., Schachter, J., Long, G. V., et al. (2015). Pembrolizumab versus Ipilimumab in Advanced Melanoma. \u003Ci>Journal of Clinical Oncology\u003C/i>, 33(13), 1340-1347.\n        \u003C/li>\n        \u003Cli>\n          Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-related adverse events associated with immune checkpoint blockade. \u003Ci>New England Journal of Medicine\u003C/i>, 378(2), 158-168.\n        \u003C/li>\n        \u003Cli>\n          Slevin, M. L., et al. (1984). Etoposide: Pharmacology, Clinical Uses, and Anti-tumor Activity. \u003Ci>Drugs\u003C/i>, 27(3), 270-292.\n        \u003C/li>\n        \u003Cli>\n          O'Dwyer, P. J., et al. (2000). Irinotecan: Pharmacology, Mechanism of Action, and Contemporary Clinical Uses. \u003Ci>Seminars in Oncology\u003C/i>, 27(4), 33-40.\u003C/li>\u003C/ol>\u003C/div>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.material-drugguide-container {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", \"Arial\", sans-serif;\n  background: #fc;\n  color: #2d364c;\n  max-width: 820px;\n  margin: 40px auto;\n  border-radius: 14px;\n  box-shadow: 0 4px 18px 0 rgba(38,44,64,0.07);\n  padding: 46px 40px 32px 40px;\n}\n\n.material-drugguide-title {\n  font-size: 34px;\n  font-weight: bold;\n  line-height: 1.18;\n  margin-bottom: 34px;\n  color: #173364;\n  letter-spacing: 1px;\n  text-align: center;\n}\n\n.material-drugguide-subtitle {\n  font-size: 23px;\n  font-weight: 500;\n  margin: 38px 0 18px 0;\n  color: #205ca8;\n  letter-spacing: 1px;\n  text-align: left;\n  position: relative;\n}\n\n.material-drugguide-bg {\n  background: linear-gradient(100deg, #f7f9fb 86%, #e5ecf7 100%);\n  border-radius: 8px;\n  padding: 22px 24px 20px 24px;\n  margin-bottom: 7px;\n  border-left: 6px solid #b6cee9;\n  box-sizing: border-box;\n  position: relative;\n}\n\n.material-bg-intro {\n  background: linear-gradient(100deg, #f5fffa 86%, #e4eff8 100%);\n  border-left-color: #96d0c2;\n}\n.material-bg-1 { background: linear-gradient(99deg, #f5f9fb 86%, #eaeef7 100%); border-left-color: #a7c5e7;}\n.material-bg-2 { background: linear-gradient(100deg, #faf5fe 90%, #ecdef7 100%); border-left-color: #cba5e0;}\n.material-bg-3 { background: linear-gradient(92deg, #fbf7fa 87%, #f7eae7 100%); border-left-color: #e8bda7;}\n.material-bg-4 { background: linear-gradient(100deg, #f9faf8 90%, #e2f4e2 100%); border-left-color: #aee3ab;}\n.material-bg-5 { background: linear-gradient(98deg, #f9f7fe 90%, #e7e7fd 100%); border-left-color: #a7b5e7;}\n.material-bg-6 { background: linear-gradient(100deg, #fff8f6 95%, #fdebda 100%); border-left-color: #ecc998;}\n.material-bg-7 { background: linear-gradient(100deg, #ecfcf8 90%, #d7f6e8 100%); border-left-color: #9bdcca;}\n.material-bg-8 { background: linear-gradient(97deg, #f8fdfe 90%, #e7f7fd 100%); border-left-color: #b6deec;}\n.material-bg-9 { background: linear-gradient(100deg, #fffcf7 90%, #ffeee0 100%); border-left-color: #ffdaa2;}\n.material-bg-ref { background: linear-gradient(100deg, #f7fafc 90%, #e9ebec 100%); border-left-color: #b6c3cb;}\n.material-bg-end { background: linear-gradient(100deg, #fcfff7 97%, #f5f8e7 100%); border-left-color: #c9e4aa;}\n\n.material-keytext {\n  font-weight: bold;\n  color: #4260a8;\n  background: #e0eaf6;\n  border-radius: 3px;\n  padding: 0 5px;\n  display: inline-block;\n}\n\n.material-tip {\n  display: inline-block;\n  background: #edf7d5;\n  color: #416320;\n  font-size: 15px;\n  font-weight: 500;\n  padding: 7px 15px 7px 13px;\n  border-radius: 7px;\n  margin-top: 18px;\n  margin-bottom: 2px;\n}\n\n.material-list {\n  margin: 18px 0 6px 0;\n  padding-left: 28px;\n  font-size: 16px;\n  line-height: 1.7;\n}\n\n.material-ref-list {\n  margin: 0 0 0 18px;\n  font-size: 15px;\n  padding-bottom: 6px;\n  color: #555b6c;\n  line-height: 1.6;\n  font-family: \"Georgia\",\"Times New Roman\",serif;\n}\n\n@media all and (max-width: 900px) {\n  .material-drugguide-container {\n    max-width: 96%;\n    padding: 12px 6px 18px 6px;\n  }\n  .material-drugguide-title { font-size: 27px;}\n  .material-drugguide-subtitle { font-size: 19px;}\n}\n\u003C/style>","\u003C!-- 胃癌四期患者常用药品安全使用指南组件 HTML 输出（2500字以上，整体美观） -->\n\u003Cdiv class=\"material-drugguide-container\">\n  \u003Ch1 i",529,"2025-10-29 00:40:43","胃癌,用药指南,老年患者,化疗药物,免疫抑制剂,靶向药物,不良反应,药物相互作用","本指南为老年胃癌四期患者提供药物安全使用的实用建议，聚焦化疗、免疫剂与靶向药物的合理应用，确保治疗安全高效。","2025-11-12 23:06:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]